A double blind randomized placebo-controlled cross-over study to validate the distinction between women with different levels of attention and valence direction for erotic stimuli, in relation to genital and subjective sexual arousal in healthy female subjects and healthy female subjects with Female Sexual Dysfunction.

Trial Profile

A double blind randomized placebo-controlled cross-over study to validate the distinction between women with different levels of attention and valence direction for erotic stimuli, in relation to genital and subjective sexual arousal in healthy female subjects and healthy female subjects with Female Sexual Dysfunction.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2012

At a glance

  • Drugs Sildenafil/testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Pharmacodynamics
  • Acronyms VAL
  • Sponsors Emotional Brain
  • Most Recent Events

    • 06 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top